Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation

Dettmer, Ulf, Newman, Andrew J., Soldner, Frank, Luth, Eric S., Kim, Nora C., von Saucken, Victoria E., Sanderson, John B., Jaenisch, Rudolf +2 more·2015·Nature Communications

Cited by (317)

Items 101–200 of 317

  1. iPSC for modeling neurodegenerative disorders
    V. Valadez-Barba, Agustín Cota-Coronado, Oscar Rene Hernandez-Perez, Pavel H. Lugo-Fabres, Eduardo Padilla‐Camberos, Néstor Fabián Díaz, Nestor Emmanuel Diaz-Martinez · 2020 · Regenerative Therapy
  2. Parkinson’s disease and multiple system atrophy patient iPSC-derived oligodendrocytes exhibit alpha-synuclein–induced changes in maturation and immune reactive properties
    Carla Azevedo, Gabriel Teku, Yuriy Pomeshchik, Juan F. Reyes, Margarita Chumarina, Kaspar Russ, Ekaterina Savchenko, Anna Hammarberg, Nuno Jorge Lamas, Anna Collin et al. · 2022 · Proceedings of the National Academy of Sciences
  3. Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson’s Disease-Relevant Phenotypes
    Samantha L. Sison, Scott Vermilyea, Marina Elena Emborg, Allison D. Ebert · 2018 · Current Neurology and Neuroscience Reports
  4. Female Sex and Brain-Selective Estrogen Benefit α-Synuclein Tetramerization and the PD-like Motor Syndrome in 3K Transgenic Mice
    Molly M. Rajsombath, Alice Y. Nam, Maria Ericsson, Silke Nuber · 2019 · Journal of Neuroscience
  5. Alpha-Synuclein and Cognitive Decline in Parkinson Disease
    Tian-Sin Fan, Sam Chi-Hao Liu, Ruey‐Meei Wu · 2021 · Life
  6. CRISPR and iPSCs: Recent Developments and Future Perspectives in Neurodegenerative Disease Modelling, Research, and Therapeutics
    Tirthankar Sen, Rajkumar P. Thummer · 2022 · Neurotoxicity Research
  7. Alpha-synuclein, autophagy-lysosomal pathway, and Lewy bodies: Mutations, propagation, aggregation, and the formation of inclusions
    Armin Bayati, Peter Scottt McPherson · 2024 · Journal of Biological Chemistry
  8. Membranes as modulators of amyloid protein misfolding and target of toxicity
    Anoop Rawat, Ralf Langen, Jobin Varkey · 2018 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  9. Refolding of helical soluble α‐synuclein through transient interaction with lipid interfaces
    Matteo Rovere, John Burdon Sanderson, Luis Fonseca‐Ornelas, Dushyant S. Patel, Tim Bartels · 2018 · FEBS Letters
  10. All Roads Lead to Rome: Different Molecular Players Converge to Common Toxic Pathways in Neurodegeneration
    Shirel Argueti-Ostrovsky, Leenor Alfahel, Joy Kahn, Adrian Israelson · 2021 · Cells
  11. Rationally Designed Variants of α-Synuclein Illuminate Its in vivo Structural Properties in Health and Disease
    Ulf Dettmer · 2018 · Frontiers in Neuroscience
  12. α-Synuclein Dimers Impair Vesicle Fission during Clathrin-Mediated Synaptic Vesicle Recycling
    Audrey T. Medeiros, Lindsey G. Soll, Isabella Tessari, Luigi Bubacco, Jennifer R. Morgan · 2017 · Frontiers in Cellular Neuroscience
  13. Cyclized NDGA modifies dynamic α-synuclein monomers preventing aggregation and toxicity
    Malcolm J. Daniels, J. Brucker Nourse, Hanna Kim, Valerio Sainati, Marco Schiavina, Maria Grazia Murrali, Buyan Pan, John Joseph Ferrie, Conor M. Haney, Rani Moons et al. · 2019 · Scientific Reports
  14. E46K-like α-synuclein mutants increase lipid interactions and disrupt membrane selectivity
    Matteo Rovere, Alex E. Powers, Haiyang Jiang, Julia C. Pitino, Luis Fonseca‐Ornelas, Dushyant S. Patel, Alessandro Achille, Ralf Langen, Jobin Varkey, Tim Bartels · 2019 · Journal of Biological Chemistry
  15. Wild-type GBA1 increases the α-synuclein tetramer–monomer ratio, reduces lipid-rich aggregates, and attenuates motor and cognitive deficits in mice
    Kelly E. Glajch, Tim E. Moors, Yi Chen, Pascal A. Bechade, Alice Y. Nam, Molly M. Rajsombath, Thomas D. McCaffery, Ulf Dettmer, Andreas Weihofen, Warren D. Hirst et al. · 2021 · Proceedings of the National Academy of Sciences
  16. Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form
    Timothy J. Collier, Kinshuk Raj Srivastava, Craig J. Justman, Tom Grammatopoulous, Birgit Hutter‐Paier, Manuela Prokesch, Daniel Havas, Jean‐Christophe Rochet, Fang Liu, Kevin Jock et al. · 2017 · Neurobiology of Disease
  17. Organoid and pluripotent stem cells in Parkinson’s disease modeling: an expert view on their value to drug discovery
    Nicolas Marotta, Soojin Kim, Dimitri Krainc · 2020 · Expert Opinion on Drug Discovery
  18. Potent inhibitors of toxic alpha-synuclein identified via cellular time-resolved FRET biosensors
    Anthony R. Braun, Elly E. Liao, Mian Horvath, Prakriti Kalra, Karen Acosta, Malaney C. Young, Noah Nathan Kochen, Chih Hung Lo, Roland Z. Brown, Michael D. Evans et al. · 2021 · npj Parkinson s Disease
  19. To be disordered or not to be disordered: is that still a question for proteins in the cell?
    Kris Pauwels, Pierre Lebrun, Péter Tompa · 2017 · Cellular and Molecular Life Sciences
  20. Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases
    Xinwen Zhang, Di Hu, Yutong Shang, Xin Qi · 2019 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  21. Iron-responsive-like elements and neurodegenerative ferroptosis
    Jack T. Rogers, Catherine M. Cahill · 2020 · Learning & Memory
  22. Palmitoylation of the Parkinson’s disease–associated protein synaptotagmin-11 links its turnover to α-synuclein homeostasis
    Gary P. H. Ho, Erin C. Wilkie, Andrew J. White, Dennis J. Selkoe · 2023 · Science Signaling
  23. Influence of EGCG on α‐synuclein (αS) aggregation and identification of their possible binding mode: A computational study using molecular dynamics simulation
    Xue‐Wei Liu, Shuangyan Zhou, Danfeng Shi, Qifeng Bai, Huanxiang Liu, Xiaojun Yao · 2017 · Chemical Biology & Drug Design
  24. iPS cells in the study of PD molecular pathogenesis
    Melanie M. Cobb, Abinaya Ravisankar, Gaia Skibinski, Steven M. Finkbeiner · 2017 · Cell and Tissue Research
  25. Alpha-Synuclein Toxicity on Protein Quality Control, Mitochondria and Endoplasmic Reticulum
    Thaiany Quevedo Melo, Sjef C.V.M. Copray, M Ferrari · 2018 · Neurochemical Research
  26. Tetramethylpyrazine Analogue T-006 Promotes the Clearance of Alpha-synuclein by Enhancing Proteasome Activity in Parkinson's Disease Models
    Hefeng Zhou, Min Shao, Baojian Guo, Chuwen Li, Yucong Lu, Xuanjun Yang, Li Shengnan, Haitao Li, Qi Zhu, Hanbing Zhong et al. · 2019 · Neurotherapeutics
  27. Rapid Alpha-Synuclein Toxicity in a Neural Cell Model and Its Rescue by a Stearoyl-CoA Desaturase Inhibitor
    Elizabeth Terry-Kantor, Arati Tripathi, Thibaut Imberdis, Zachary M. LaVoie, Gary P. H. Ho, Dennis J. Selkoe, Saranna Fanning, Nagendran Ramalingam, Ulf Dettmer · 2020 · International Journal of Molecular Sciences
  28. Modelling Parkinson’s Disease: iPSCs towards Better Understanding of Human Pathology
    Sahar Avazzadeh, Jara M. Baena-Montes, Cameron Noah Keighron, Yajaira Feller Sánchez, Leo R. Quinlan · 2021 · Brain Sciences
  29. Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies
    D. Pazzin, T. Previato, João Ismael Budelon Gonçalves, G. Zanirati, F. Xavier, J. C. da Costa, D. Marinowic · 2024 · Cells
  30. Upregulation of Cellular Palmitoylation Mitigates α‐Synuclein Accumulation and Neurotoxicity
    Gary P. H. Ho, Nagendran Ramalingam, Thibaut Imberdis, Erin C. Wilkie, Ulf Dettmer, Dennis J. Selkoe · 2020 · Movement Disorders
  31. Intrinsically disordered proteins in various hypotheses on the pathogenesis of Alzheimer's and Parkinson's diseases
    Orkid Coskuner‐Weber, Vladimir Nikolaevich Uversky · 2019 · Progress in molecular biology and translational science
  32. Altered Protein Palmitoylation as Disease Mechanism in Neurodegenerative Disorders
    Jakub Włodarczyk, Raja Bhattacharyya, Kim Doré, Gary P. H. Ho, Dale D. O. Martin, Rebeca Mejı́as, Karin Hochrainer · 2024 · Journal of Neuroscience
  33. The Bidirectional Interplay of α-Synuclein with Lipids in the Central Nervous System and Its Implications for the Pathogenesis of Parkinson’s Disease
    Kristina Battis, Wei Xiang, Jürgen Winkler · 2023 · International Journal of Molecular Sciences
  34. Current insights and assumptions on α-synuclein in Lewy body disease
    Rehana K. Leak, Rachel N. Clark, Muslim Abbas, Fei Xu, Jeffrey L. Brodsky, Jun Chen, Xiaoming Hu, Kelvin C. Luk · 2024 · Acta Neuropathologica
  35. Cross‐linking for the analysis of α‐synuclein in the enteric nervous system
    Anne-Gaëlle Corbillé, Michel Neunlist, Pascal Derkinderen · 2016 · Journal of Neurochemistry
  36. Brain region-specific susceptibility of Lewy body pathology in synucleinopathies is governed by α-synuclein conformations
    Laura de Boni, Aurelia Hays Watson, Ludovica Zaccagnini, Amber Wallis, Kristina Zhelcheska, Nora Kim, John Burdon Sanderson, Haiyang Jiang, Elodie Martin, Adam Cantlon et al. · 2022 · Acta Neuropathologica
  37. Copper Induced Radical Dimerization of α-Synuclein Requires Histidine
    Dinendra L. Abeyawardhane, Ricardo D. Fernández, Denver R. Heitger, Madeleine K. Crozier, Julia C. Wolver, Heather R. Lucas · 2018 · Journal of the American Chemical Society
  38. Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synuclein
    Charlotte F. Brzozowski, Baraa A. Hijaz, Vijay Singh, Nolwazi Z. Gcwensa, Kaela Kelly, Edward S. Boyden, Andrew B. West, Deblina Sarkar, Laura A. Volpicelli‐Daley · 2021 · Acta Neuropathologica Communications
  39. A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein Toxicity
    Silke Nuber, Chee Yeun Chung, Daniel F. Tardiff, Pascal A. Bechade, Thomas D. McCaffery, Kazuma Shimanaka, Jeonghoon Choi, Belle Chang, Waseem Khan Raja, Esther Neves et al. · 2022 · Neurotherapeutics
  40. Site-Specific Fluorescence Polarization for Studying the Disaggregation of α-Synuclein Fibrils by Small Molecules
    Conor M. Haney, Christina L. Cleveland, Rebecca F. Wissner, Lily Owei, Jaclyn Robustelli, Malcolm J. Daniels, Merve Canyurt, Priscilla Rodriguez, Harry Ischiropoulos, Tobias Baumgart et al. · 2016 · Biochemistry
  41. Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous α-synuclein in human neurons
    Luis Fonseca‐Ornelas, Jonathan M. S. Stricker, Stephanie Soriano-Cruz, Beatrice Weykopf, Ulf Dettmer, Christina Muratore, Clemens R. Scherzer, Dennis J. Selkoe · 2022 · npj Parkinson s Disease
  42. Alpha-synuclein in skin as a high-quality biomarker for Parkinson's disease
    Haoran Peng, Siyuan Chen, Shaopu Wu, Xiaoxue Shi, Jianjun Ma, Hongqi Yang, Xue Li · 2023 · Journal of the Neurological Sciences
  43. Using induced pluripotent stem cells for modeling Parkinson’s disease
    Minjing Ke, Cheong‐Meng Chong, Huanxing Su · 2019 · World Journal of Stem Cells
  44. Modeling Cell-Cell Interactions in Parkinson’s Disease Using Human Stem Cell-Based Models
    Katrin Simmnacher, Jonas Lanfer, Tania Rizo, Johanna Kaindl, Beate Winner · 2020 · Frontiers in Cellular Neuroscience
  45. Monitoring alpha‐synuclein oligomerization and aggregation using bimolecular fluorescence complementation assays: What you see is not always what you get
    Bryan Frey, Abdelrahman AlOkda, Matthew P. Jackson, Nathan Riguet, James A. Duce, Hilal Ahmed Lashuel · 2020 · Journal of Neurochemistry
  46. Patient-Derived Induced Pluripotent Stem Cell-Based Models in Parkinson’s Disease for Drug Identification
    Georgia Kouroupi, Nasia Antoniou, Kanella Prodromidou, Era Taoufik, Rebecca Matsas · 2020 · International Journal of Molecular Sciences
  47. Mobile phone electromagnetic radiation affects Amyloid Precursor Protein and α-synuclein metabolism in SH-SY5Y cells
    Aikaterina L. Stefi, Lukas H. Margaritis, Aikaterini Skouroliakou, Dido Vassilacopoulou · 2019 · Pathophysiology
  48. Unveiling the Role of DJ‐1 Protein in Vesicular Storage and Release of Catecholamine with Nano/Micro‐Tip Electrodes
    Qingwei Yue, Xianchan Li, Fei Wu, Wenliang Ji, Yue Zhang, Ping Yu, Meining Zhang, Wenjie Ma, Ming Wang, Lanqun Mao · 2020 · Angewandte Chemie
  49. Model Senescent Microglia Induce Disease Related Changes in α-Synuclein Expression and Activity
    Dafina M. Angelova, David R. Brown · 2018 · Biomolecules
  50. Pathogenic Mechanisms of Cytosolic and Membrane-Enriched α-Synuclein Converge on Fatty Acid Homeostasis
    Arati Tripathi, Heba Alnakhala, Elizabeth Terry-Kantor, Andrew Newman, Lei Liu, Thibaut Imberdis, Saranna Fanning, Silke Nuber, Nagendran Ramalingam, Dennis Selkoe et al. · 2022 · Journal of Neuroscience
  51. Lipase regulation of cellular fatty acid homeostasis as a Parkinson’s disease therapeutic strategy
    Saranna Fanning, Haley Cirka, Jennifer L. Thies, Jooyoung Jeong, Sarah M. Niemi, Joon Ho Yoon, Gary P. H. Ho, Julián Ávila-Pacheco, Ulf Dettmer, Lei Liu et al. · 2022 · npj Parkinson s Disease
  52. Solution NMR of SNAREs, complexin and α-synuclein in association with membrane-mimetics
    Binyong Liang, Lukas K. Tamm · 2018 · Progress in Nuclear Magnetic Resonance Spectroscopy
  53. Ganglioside Metabolism and Parkinson's Disease
    John Forsayeth, Piotr Hadaczek · 2018 · Frontiers in Neuroscience
  54. Large-scale visualization of α-synuclein oligomers in Parkinson’s disease brain tissue
    Rebecca Andrews, Bin Fu, Christina E. Toomey, Jonathan C. Breiter, Joanne Lachica, Joseph S. Beckwith, Ru Tian, Emma E. Brock, Lisa-Maria Needham, Gregory J. Chant et al. · 2025 · Nature Biomedical Engineering
  55. Environmentally sensitive probes for monitoring protein-membrane interactions at nanomolar concentrations
    Volodymyr V. Shvadchak, Oleksandr A. Kucherak, Kseniia Afitska, Dmytro Dziuba, Dmytro A. Yushchenko · 2017 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  56. In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons
    Maria Fouka, Panagiota Mavroeidi, Grigoria Tsaka, Maria Xilouri · 2020 · Frontiers in Cell and Developmental Biology
  57. Poly (ADP-ribose) Interacts With Phosphorylated α-Synuclein in Post Mortem PD Samples
    Laura N. Puentes, Zsofia Lengyel‐Zhand, Ji Youn Lee, Chia‐Ju Hsieh, Mark E. Schneider, Kimberly J. Edwards, Kelvin C. Luk, Virginia M.‐Y. Lee, John Q. Trojanowski, Robert H. Mach · 2021 · Frontiers in Aging Neuroscience
  58. NLRP3 inflammasome pathway is involved in olfactory bulb pathological alteration induced by MPTP
    Ying Chen, Qiu-Shuang Zhang, Qian-Hang Shao, Shuo Wang, Yu‐He Yuan, Nai‐Hong Chen, Hongbo Wang · 2019 · Acta Pharmacologica Sinica
  59. Binding of Noradrenaline to Native and Intermediate States during the Fibrillation of α-Synuclein Leads to the Formation of Stable and Structured Cytotoxic Species
    Priyanka Singh, Rajiv Bhat · 2019 · ACS Chemical Neuroscience
  60. Navigating the dynamic landscape of alpha-synuclein morphology: a review of the physiologically relevant tetrameric conformation
    Heather R. Lucas, Ricardo D. Fernández · 2019 · Neural Regeneration Research
  61. A sensitive assay reveals structural requirements for α-synuclein fibril growth
    Dhruva D. Dhavale, Christina Tsai, Devika P. Bagchi, Laura A. Engel, Jonathan Sarezky, Paul T. Kotzbauer · 2017 · Journal of Biological Chemistry
  62. Isolation of recombinant tetrameric N-acetylated α-synuclein
    Ricardo D. Fernández, Heather R. Lucas · 2018 · Protein Expression and Purification
  63. Modeling Neuropsychiatric and Neurodegenerative Diseases With Induced Pluripotent Stem Cells
    Elizabeth A. LaMarca, Samuel K. Powell, Schahram Akbarian, Kristen Brennand · 2018 · Frontiers in Pediatrics
  64. Re-designing the α-synuclein tetramer
    Liang Xu, Shayon Bhattacharya, Damien Thompson · 2018 · Chemical Communications
  65. Individual Amino Acid Supplementation Can Improve Energy Metabolism and Decrease ROS Production in Neuronal Cells Overexpressing Alpha-Synuclein
    Vedad Delic, Jeddidiah W. D. Griffin, Sandra Zivkovic, Yumeng Zhang, Tam-Anh Phan, Henry Gong, Dale Chaput, Christian Reynes, Vinh B. Dinh, Josean Cruz et al. · 2017 · NeuroMolecular Medicine
  66. Vertebrate food products as a potential source of prion-like α-synuclein
    Bryan A. Killinger, Viviane Labrie · 2017 · npj Parkinson s Disease
  67. Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons
    Emanuela Colla, Giulia Panattoni, Alessio Ricci, Caterina Rizzi, Lucia Rota, Nicola Maria Carucci, Verdiana Valvano, Francesco Gobbo, Simona Capsoni, Michael K. Lee et al. · 2017 · Neurobiology of Disease
  68. Effects of Excess Brain-Derived Human α-Synuclein on Synaptic Vesicle Trafficking
    Cristina Román‐Vendrell, Audrey T. Medeiros, John Burdon Sanderson, Haiyang Jiang, Tim Bartels, Jennifer R. Morgan · 2021 · Frontiers in Neuroscience
  69. Human Neural Progenitor Transplantation Rescues Behavior and Reduces α-Synuclein in a Transgenic Model of Dementia with Lewy Bodies
    Natalie R.S. Goldberg, Samuel E. Marsh, Joseph Ochaba, Brandon Shelley, Hayk Davtyan, Leslie Michels Thompson, Joan S. Steffan, Clive Niels Svendsen, Mathew M. Blurton-Jones · 2017 · Stem Cells Translational Medicine
  70. Equine pituitary pars intermedia dysfunction: a spontaneous model of synucleinopathy
    Jessica S. Fortin, Ashley A. Hetak, Kelsey E. Duggan, Caroline M. Burglass, Hailey B. Penticoff, Harold C. Schott · 2021 · Scientific Reports
  71. Dynamic reversibility of α‐synuclein serine‐129 phosphorylation is impaired in synucleinopathy models
    Nagendran Ramalingam, Lisa Brontesi, Shan‐Xue Jin, Dennis J. Selkoe, Ulf Dettmer · 2023 · EMBO Reports
  72. Endogenous Alpha-Synuclein Protein Analysis from Human Brain Tissues Using Single-Molecule Pull-Down Assay
    Goun Je, Benjamin Croop, Sambuddha Basu, Jialei Tang, Kyu Young Han, Yoon-Seong Kim · 2017 · Analytical Chemistry
  73. Dynamic behaviors of α-synuclein and tau in the cellular context: New mechanistic insights and therapeutic opportunities in neurodegeneration
    Fred Yeboah, Taeeun Kim, Anke Bill, Ulf Dettmer · 2019 · Neurobiology of Disease
  74. The Neuroprotective Role of Protein Quality Control in Halting the Development of Alpha-Synuclein Pathology
    Manecka, Destiny-Love, Vanderperre, Benoît, Fon, Edward A., Durcan, Thomas M. · 2017 · Frontiers in Molecular Neuroscience
  75. New therapeutic approaches to target alpha-synuclein in Parkinson's disease: The role of immunotherapy
    Tamara Fernández‐Valle, Iñigo Gabilondo, Juan Carlos Gómez‐Esteban · 2019 · International review of neurobiology
  76. Nuclear Magnetic Resonance Observation of α-Synuclein Membrane Interaction by Monitoring the Acetylation Reactivity of Its Lysine Side Chains
    Jung Ho Lee, Jinfa Ying, Ad Bax · 2016 · Biochemistry
  77. Monomeric α‐synuclein activates the plasma membrane calcium pump
    Antoni Kowalski, Cristine Betzer, Sigrid Thirup Larsen, Emil Gregersen, Estella A. Newcombe, Montaña Caballero Bermejo, Viktor Wisniewski Bendtsen, Jorin Diemer, Christina V. Ernstsen, Shweta Jain et al. · 2023 · The EMBO Journal
  78. Towards understanding cellular structure biology: In-cell NMR
    Safikur Rahman, Younhwa Byun, Md. Imtaiyaz Hassan, Jihoe Kim, Vijay Kumar · 2017 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  79. Neurodegenerative Diseases and Ageing
    Lauren Walker, Kirsty E. McAleese, Daniel Erskine, Johannes Attems · 2019 · Sub-cellular biochemistry/Subcellular biochemistry
  80. Crowded organelles, lipid accumulation, and abnormal membrane tubulation in cellular models of enhanced α-synuclein membrane interaction
    Maria Ericsson, Victoria E. von Saucken, Andrew J Newman, Lena Doehr, Camilla Hoesch, Tae‐Eun Kim, Ulf Dettmer · 2021 · Brain Research
  81. α-Synuclein Conformational Plasticity: Physiologic States, Pathologic Strains, and Biotechnological Applications
    Amanda Li, Cyrus T. Rastegar, Xiaobo Mao · 2022 · Biomolecules
  82. Patient-derived three-dimensional cortical neurospheres to model Parkinson’s disease
    Waseem Khan Raja, Esther Neves, Christopher Burke, Xin Jian Jiang, Ping Xu, Kenneth J. Rhodes, Vikram Khurana, Robert H. Scannevin, Chee Yeun Chung · 2022 · PLoS ONE
  83. An extract of the marine alga Alaria esculenta modulates α-synuclein folding and amyloid formation.
    J. Giffin, Robert C. Richards, Cheryl Craft, N. Jahan, C. Leggiadro, T. Chopin, M. Szemerda, S. Mackinnon, K. Ewart · 2017 · Neuroscience Letters
  84. How important is the N-terminal acetylation of alpha-synuclein for its function and aggregation into amyloids?
    Aditya Iyer, Arshdeep Sidhu, Vinod Subramaniam · 2022 · Frontiers in Neuroscience
  85. Histone Deacetylase 4 Inhibition Reduces Rotenone-Induced Alpha-Synuclein Accumulation via Autophagy in SH-SY5Y Cells
    Luxi Wang, Ling Liu, Chao Han, Haiyang Jiang, Kai Ma, Shiyi Guo, Yun Fei Xia, Fang Jung Wan, Jinsha Huang, Nian Xiong et al. · 2023 · Brain Sciences
  86. Insights into GBA Parkinson's disease pathology and therapy with induced pluripotent stem cell model systems
    Pascale Baden, Cong Yu, Michela Deleidi · 2019 · Neurobiology of Disease
  87. Molecular Dynamics Study of the Interaction between the N-terminal of α-Synuclein and a Lipid Bilayer Mimicking Synaptic Vesicles
    Christopher Kang, Rui Sun · 2020 · The Journal of Physical Chemistry B
  88. α-Synuclein ubiquitination – functions in proteostasis and development of Lewy bodies
    Hung-Hsiang Ho, Simon S. Wing · 2024 · Frontiers in Molecular Neuroscience
  89. Reducing the lipase LIPE in mutant α-synuclein mice improves Parkinson-like deficits and reveals sex differences in fatty acid metabolism
    Marie-Alexandre Adom, Wolf N. Hahn, T.D. McCaffery, Tim E. Moors, X. Zhang, Per Svenningsson, Dennis J. Selkoe, Saranna Fanning, Silke Nuber · 2024 · Neurobiology of Disease
  90. Trends in glycolipid biomarker discovery in neurodegenerative disorders by mass spectrometry
    Dehelean, Liana, Sarbu, Mirela, Petrut, Alina, Zamfir, Alina D. · 2019 · Advances in experimental medicine and biology
  91. The Parkinson-Associated Toxin Paraquat Shifts Physiological α-Synuclein Tetramers toward Monomers That Can Be Calpain-Truncated and Form Oligomers
    Silke Nuber, Dennis J. Selkoe · 2023 · American Journal Of Pathology
  92. Increased palmitoylation improves estrogen receptor alpha–dependent hippocampal synaptic deficits in a mouse model of synucleinopathy
    Tim E. Moors, Shaomin Li, Thomas D. McCaffery, Gary P. H. Ho, Pascal A. Bechade, Luu N. Pham, Maria Ericsson, Silke Nuber · 2023 · Science Advances
  93. Locked in a vicious cycle: the connection between genomic instability and a loss of protein homeostasis
    Wouter Huiting, Steven Bergink · 2020 · Genome Instability & Disease
  94. Excess membrane binding of monomeric alpha-, beta- and gamma-synuclein is invariably associated with inclusion formation and toxicity
    Tae‐Eun Kim, Andrew J Newman, Thibaut Imberdis, Lisa Brontesi, Arati Tripathi, Nagendran Ramalingam, Saranna Fanning, Dennis J. Selkoe, Ulf Dettmer · 2021 · Human Molecular Genetics
  95. Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson’s Disease
    Jeffrey J. Kim, Etienne W. Daadi, Thomas T Oh, Elyas S. Daadi, Marcel M. Daadi · 2022 · Genes
  96. Caspase-1 clipping causes complications for α-synuclein
    Silke Nuber, Dennis J. Selkoe · 2016 · Proceedings of the National Academy of Sciences
  97. Biophysical studies of protein misfolding and aggregation in in vivo models of Alzheimer's and Parkinson's diseases
    Tessa Sinnige, Karen Stroobants, Christopher Martin Dobson, Michele Vendruscolo · 2020 · Quarterly Reviews of Biophysics
  98. Biophysical studies of protein misfolding and aggregation in in vivo models of Alzheimer's and Parkinson's diseases – ERRATUM
    Tessa Sinnige, Karen Stroobants, Christopher Martin Dobson, Michele Vendruscolo · 2020 · Quarterly Reviews of Biophysics
  99. Zn 2 + Binding Shifts the Conformational Ensemble of α-Synuclein Monomers toward Accelerated Amyloid Formation
    Emily J. Byrd, Benjamin Rowlinson, Joel A. Crossley, David J. Brockwell, James F. Ross, Sheena E. Radford, Frank Sobott · 2025 · Journal of the American Chemical Society
  100. E46K mutant α-synuclein is more degradation resistant and exhibits greater toxic effects than wild-type α-synuclein in Drosophila models of Parkinson's disease
    Ryusuke Sakai, Mari Suzuki, Morio Ueyama, Toshihide Takeuchi, Eiko Nakano Minakawa, Hideki Hayakawa, Kousuke Baba, Hideki Mochizuki, Yoshitaka Nagai · 2019 · PLoS ONE